Article Versions Notes

Henes JC, Saur S, Kofler DM, Kedor C, Meisner C, Schuett M, Krusche M, Koetter I, Xenitidis T, Schulze-Koops H, et al. Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Journal of Clinical Medicine. 2022; 11(18):5360. https://doi.org/10.3390/jcm11185360

Henes, Joerg C., Sebastian Saur, David M. Kofler, Claudia Kedor, Christoph Meisner, Marion Schuett, Martin Krusche, Ina Koetter, Theodoros Xenitidis, Hendrik Schulze-Koops, and et al. 2022. "Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study" Journal of Clinical Medicine 11, no. 18: 5360. https://doi.org/10.3390/jcm11185360

Henes, J. C., Saur, S., Kofler, D. M., Kedor, C., Meisner, C., Schuett, M., Krusche, M., Koetter, I., Xenitidis, T., Schulze-Koops, H., & Feist, E., on behalf of the TOFFIFE Study Team. (2022). Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Journal of Clinical Medicine, 11(18), 5360. https://doi.org/10.3390/jcm11185360